Based on the provided data, the forecasted turnover per employee in the biotechnology research and experimental development sector in France shows a slight year-on-year decline from 2024 to 2028. The turnover per employee is expected to drop from 131.7 thousand euros in 2024 to 129.6 thousand euros by 2028. Comparing 2024 to 2023, there is a noticeable declining trend in the figures. Over the five-year forecast period, the compound annual growth rate (CAGR) indicates a subtle decrease in turnover per employee, averaging a yearly reduction.
Future trends to watch for include potential impacts of regulatory changes, technological advancements in biotech, and shifts in funding patterns. Additionally, the influence of global economic conditions and competitive pressures may further affect turnover rates and sector performance in the coming years.
